Cognitive Behavioral Therapy (CBT) and the Third Wave Syndrome-based treatments have dominated the evidence-based landscape for almost 50 years. This syndrome approach has served well to increase diagnostic reliability and develop scientific treatment packages. However, the age of “which evidence-based package is the best?” is coming to an end. The question moving forward is “which shared mechanisms across disorders and treatments should be targeted”? This “transdiagnostic” or “third wave” approach has been welcomed by the National Institute of Mental Health (NIMH), signaling process-based therapy (PBT) as the future of evidence based-practice. Targeting shared processes such as “psychological flexibility”, which cut across syndromes, will simplify complex interventions, better treat comorbid presentations… Read More
Continue ReadingInnovations in Relapse Prevention
Dr. Berman will be presenting his research at the American Society of Addiction Medicine (ASAM) conference in April. Please click on the link below to learn more about Dr. Berman’s abstract and research team. Transdiagnostic and Self-Compassionate Innovations in Relapse Prevention
Continue ReadingDr. Berman’s Newest Research
Dr. Berman and his team have been accepted to present research on the impact of transdiagnostic approaches on treatment adherence at the American Psychological Association (APA) 2020 Convention. Stay tuned for updates and information.
Continue Reading